Sumpatan, Noralyn T.
HRN: 23-18-32 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CO-AMOXICLAV 625MG (TAB)
05/21/2026
05/27/2026
PO
625mg
BID
UTI Following Delivery
Checking Initial Appropriateness